Xeris Biopharma Reports First Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. NVDA
2. HD
3. AMLX
4. METC
5. SPY
6. DOO
7. ARGX

Go back to Xeris Biopharma Reports First Quarter 2026 Financial Results
(NASDAQ: XERS) Delayed: 8.85 +0.33 (3.87%)
Previous Close $8.52    52 Week High $ 
Open $8.58    52 Week Low $ 
Day High $8.88    P/E N/A 
Day Low $8.47    EPS $ 
Volume 2,137,182